Jan 30 (Reuters) - Novo Nordisk's Wegovy pill hit over 26,000 U.S. prescriptions in the second full week after its launch, ...

Novo Nordisk's Wegovy pill hits over 26,000 U.S. prescriptions in the second full week after its launch, IQVIA data shared by ...

The UK warned some patients have died of severe inflammation of the pancreas linked to obesity and diabetes drugs such as Eli Lilly and Co.’s Mounjaro and Novo Nordisk A/S’s Wegovy.

The pill version of Wegovy seems to work just as well as the injectable form, but there are some key differences between the ...

By Harshita Mary Varghese and Patrick Wingrove Jan 28 (Reuters) - Novo Nordisk spent nearly $500 million on U.S. advertising ...

Popular weight-loss drugs are meant to be lifelong medications treating a disease, not lifestyle fixes.

With just a few months to go before Eli Lilly expects to launch its own oral GLP-1 obesity drug, Novo Nordisk is making the ...

Does the new Wegovy pill work as well as Wegovy injections for weight loss? How else does it compare? Learn what the experts ...

MNT speaks with three obesity medicine experts to find out more about the FDA-aproved Wegovy pill and how it's different from the Wegovy injection.

In December, Novo Nordisk announced that the Food and Drug Administration had approved its once-daily Wegovy pill, the first oral GLP-1 medicine for obesity in the United States. It remains the only ...

Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.

Novo Nordisk sharply increased U.S. advertising for Wegovy and Ozempic in 2025, outspending Eli Lilly as competition for obesity drugs intensified.